Scholarlink

<p>NEDD4-2, a ubiquitin ligase, regulates a number of ion channels and transporters by promoting their ubiquitination, internalisation and degradation, thereby affecting many signalling and physiological outcomes. Loss of this gene in mice results in tubular cell death and a chronic kidney disease (CKD)-like phenotype due to aberrant Na<sup>+</sup> transport, caused by elevated expression of NEDD4-2 substrates including the epithelial sodium channel (ENaC). One of the biggest risk factors for CKD is diabetes, as up to 50% of diabetic patients develop diabetic kidney disease (DKD). Reduced levels of <i>Nedd4-2</i> are associated with DKD in patients, therefore we investigated if this gene contributes to the development of this disease. In a diabetic (db/db) mouse model that develops DKD, we observed reduced expression of <i>Nedd4-2</i> that correlated with disease progression. Substrates of NEDD4-2, including ENaC, were elevated in db/db mice, suggesting that NEDD4-2 dysfunction is involved in disease pathology. Intriguingly, genetic ablation of <i>Nedd4-2</i> in this diabetic model did not exacerbate kidney disease severity beyond <i>Nedd4-2</i> loss alone, but corrected metabolic parameters via a reduction of aldosterone levels, restoration of insulin signaling and reduced blood glucose levels. Hence, we conclude that a reduced <i>Nedd4-2</i> level is detrimental for kidney health, however unexpectedly improves glycemic control in diabetes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nedd4-2 ablation in kidney improves glycaemic control in diabetic mice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月5日

查看全文
  • Jantina A. Manning,
  • Shilpanjali Jesudason,
  • Paul A. B. Moretti,
  • Stuart M. Pitson,
  • Angela S. Y. Chou,
  • Meriam Shabbar,
  • Sonia Saad,
  • Carol Pollock,
  • Sharad Kumar

摘要

NEDD4-2, a ubiquitin ligase, regulates a number of ion channels and transporters by promoting their ubiquitination, internalisation and degradation, thereby affecting many signalling and physiological outcomes. Loss of this gene in mice results in tubular cell death and a chronic kidney disease (CKD)-like phenotype due to aberrant Na+ transport, caused by elevated expression of NEDD4-2 substrates including the epithelial sodium channel (ENaC). One of the biggest risk factors for CKD is diabetes, as up to 50% of diabetic patients develop diabetic kidney disease (DKD). Reduced levels of Nedd4-2 are associated with DKD in patients, therefore we investigated if this gene contributes to the development of this disease. In a diabetic (db/db) mouse model that develops DKD, we observed reduced expression of Nedd4-2 that correlated with disease progression. Substrates of NEDD4-2, including ENaC, were elevated in db/db mice, suggesting that NEDD4-2 dysfunction is involved in disease pathology. Intriguingly, genetic ablation of Nedd4-2 in this diabetic model did not exacerbate kidney disease severity beyond Nedd4-2 loss alone, but corrected metabolic parameters via a reduction of aldosterone levels, restoration of insulin signaling and reduced blood glucose levels. Hence, we conclude that a reduced Nedd4-2 level is detrimental for kidney health, however unexpectedly improves glycemic control in diabetes.